Calculation
P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income (loss) from operations1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26, 2024 | 61.09 | = | 259.89 | ÷ | 4.25 | 4.25 | = | 159,093 | ÷ | 37,396,816 | |
Feb 27, 2023 | 55.72 | = | 189.52 | ÷ | 3.40 | 3.40 | = | 124,134 | ÷ | 36,495,387 | |
Feb 25, 2022 | — | = | 175.59 | ÷ | -0.02 | -0.02 | = | -871 | ÷ | 35,653,563 | |
Feb 26, 2021 | — | = | 116.76 | ÷ | -1.88 | -1.88 | = | -65,663 | ÷ | 34,842,744 | |
Mar 12, 2020 | — | = | 29.00 | ÷ | -1.63 | -1.63 | = | -51,839 | ÷ | 31,765,657 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Shockwave Medical Inc. Annual Report.
Comparison to Competitors
Shockwave Medical Inc. | Abbott Laboratories | Cigna Group | CVS Health Corp. | Humana Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|---|---|
Feb 26, 2024 | 61.09 | 30.54 | 11.51 | 6.96 | 10.94 | 75.42 | 21.20 | 14.20 |
Feb 27, 2023 | 55.72 | 22.18 | 10.40 | 14.75 | 16.63 | 54.49 | 20.48 | 15.89 |
Feb 25, 2022 | — | 24.45 | 9.08 | 10.43 | 17.08 | 56.11 | 37.44 | 18.77 |
Feb 26, 2021 | — | 40.69 | 9.03 | 6.65 | 9.78 | 88.37 | 26.29 | 14.12 |
Mar 12, 2020 | — | 34.03 | 8.38 | 7.83 | 15.35 | 48.89 | 21.26 | 14.40 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).